ObsEva SA said its shares will begin trading on the SIX Swiss Exchange on July 13.

ObsEva's shares will be listed under the ticker OBSN. The Swiss biopharmaceutical company will not issue any new shares in connection with the listing in Switzerland.

The company has been listed on the Nasdaq Global Select Market since January 2017.

ObsEva anticipates a market capitalization of about CHF650 million.

Switzerland-based ObsEva develops and sells therapeutics for serious conditions related to women's reproductive health.